USAQ
QHSLab, Inc. OTC$0.59
Mkt Cap $6.7M
52w Low $0.08
48.3% of range
52w High $1.14
50d MA $0.64
200d MA $0.42
P/E (TTM)
15.5x
EV/EBITDA
7.9x
P/B
4.3x
Debt/Equity
0.0x
ROE
28.1%
P/FCF
38.4x
RSI (14)
—
ATR (14)
—
Beta
0.65
50d MA
$0.64
200d MA
$0.42
Avg Volume
3.1K
About
QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. In addition, the company provides quality health score lab expert system (QHSL…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | AMC | — | 0.05 | — | 0.57 | +7.0% | +8.2% | +21.0% | +18.4% | -12.3% | +14.0% | -3.9% | — |
| Nov 13, 2025 | AMC | — | 0.00 | — | 0.16 | +0.0% | +0.0% | +0.0% | +51.8% | +28.0% | +28.0% | +89.0% | — |
| Aug 14, 2025 | AMC | — | -0.00 | — | 0.19 | +0.0% | +0.0% | +0.0% | +0.5% | +0.5% | +0.5% | -18.1% | — |
| May 14, 2025 | AMC | — | -0.01 | — | 0.17 | +11.2% | +26.5% | +39.7% | +91.2% | +52.9% | +55.9% | +17.4% | — |
| Mar 28, 2025 | AMC | — | -0.03 | — | 0.25 | +0.0% | +0.0% | -12.0% | -12.0% | -20.0% | -20.0% | -25.6% | — |
| Nov 13, 2024 | AMC | — | 0.00 | — | — | — | — | — | — | — | — | — | — |
| Aug 14, 2024 | AMC | — | -0.00 | — | — | — | — | — | — | — | — | — | — |
| May 13, 2024 | AMC | — | -0.00 | — | 0.10 | +18.0% | +18.0% | +8.0% | +15.0% | +15.0% | +20.0% | +123.4% | — |
| Mar 27, 2024 | AMC | — | -0.01 | — | 0.10 | -21.2% | -13.1% | -13.2% | -27.0% | -18.1% | -19.0% | -5.5% | — |
| Nov 13, 2023 | AMC | -0.01 | -0.01 | +11.0% | 0.03 | +2.9% | +2.9% | -54.4% | -11.8% | +0.0% | — | -2.9% | — |
Recent Filings
8-K · 7.01
! Medium
QHSLab, Inc. -- 8-K 7.01: Regulation FD Disclosure
QHSLab, Inc. disclosed material information through a press release, potentially signaling company developments that could affect USAQ shareholders' investment decisions.
Apr 21
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
QHS Labs is establishing social media channels as official disclosure platforms, potentially increasing information accessibility but creating operational risk if communications lack the rigor of formal SEC filings.
Mar 31
Data updated apr 28, 2026 11:52pm
· Source: massive.com